Responses
Clinical science
Predictors of treatment response to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for choroidal neovascularisation secondary to chronic central serous chorioretinopathy
Compose a Response to This Article
Other responses
No responses have been published for this article.